Pure Global AI
NCT06317272Terminated

BReath Hold TecHniquEs for Radiotherapy of Esophageal Carcinoma

BReath hOld TecHniquEs for Radiotherapy of Esophageal Carcinoma; a Feasibility Study - Part 1
University Medical Center GroningenClinicalTrials.govother
Verified
Study focus
Disease/Condition
Esophageal Cancer
Drug/Device/Intervention
DIBH using ABC technique
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University Medical Center Groningen
Location
Groningen, Netherlands
Timeline & enrollment
Phase
N/A
Start date
Feb 10, 2021
End date
Sep 19, 2023
Enrollment
1 participants
Primary outcome

Feasibility DIBH,Reproducibility DIBH

Summary

The main objective of the first part of the study is to determine the most optimal method for
 DIBH (active breathing control vs voluntary coached) and its reproducibility. Based on these
 findings, one of these methods will be selected for part 2 of this study.

ICD-10 classifications
Carcinoma in situ: OesophagusMalignant neoplasm of oesophagusMalignant neoplasm: Middle third of oesophagusMalignant neoplasm: Overlapping lesion of oesophagusMalignant neoplasm: Upper third of oesophagus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06317272
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06317272 through Pure Global AI's free database. This phase not specified trial is sponsored by University Medical Center Groningen and is currently Terminated. The study focuses on Esophageal Cancer. Target enrollment is 1 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.